FIELD: biotechnology.
SUBSTANCE: describes a nucleic acid molecule comprising a double-stranded structure, wherein the double-stranded structure is formed by a first chain and a second chain, where the first chain consists of the following nucleotide sequence: 5'-acGaGcUgGaCcAcUgGuCdTSdT-3' and the second chain consists of the following nucleotide sequence: 5'-GAcCaGuGgUcCaGcUcGudTSdT-3', where the nucleotide is indicated by a lowercase letter, indicates that the nucleotide is 2'-F-modified, and underlining of the nucleotide indicates that the nucleotide is 2'-O-methyl-modified and where dTSdT indicates that a dinucleotide consisting of two nucleotides dT is attached at the 3'-end, wherein the two dT are covalently linked via a phosphothioate bond. Described is the use of the disclosed nucleic acid molecule in the preparation of means for restoring the sensitivity of malignant cells to a drug and for the treatment and/or prevention of a disease.
EFFECT: pharmaceutical composition and a nanoemulsion containing the described nucleic acid molecule are provided.
111 cl, 5 dwg, 3 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
MOLECULES OF NUCLEIC ACID, WHICH EFFECT SUBUNIT FROM VACUOLAR ATPHASE AND GIVE RESISTANCE TO COLEOPTEROUS INSECT PESTS | 2011 |
|
RU2644669C2 |
TREATING DISEASES ASSOCIATED WITH VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) BY SUPPRESSION OF NATURAL ANTISENSE VEGF TRANSCRIPT | 2009 |
|
RU2569182C2 |
METHODS AND COMPOSITIONS FOR TREATMENT OF SERPINC1-ASSOCIATED DISORDER | 2016 |
|
RU2754188C2 |
OLIGIRIBONUCLEOTIDES AND METHODS OF THEIR APPLICATION FOR TREATMENT OF ACUTE RENAL FAILURE AND OTHER DISEASES | 2005 |
|
RU2434942C2 |
OLIGORIBONUCLEOTIDES AND METHODS OF THEIR APPLICATION FOR TREATMENT OF ACUTE RENAL FAILURE | 2005 |
|
RU2584609C2 |
NUCLEIC ACIDS MOLECULES THAT PROVIDE RESISTANCE TO BEETLE PESTS | 2011 |
|
RU2639549C2 |
PREPARATIONS PROVIDING RNA-INTERFERENCE FOR GST-PI GENE MODULATION | 2015 |
|
RU2719185C2 |
COMBINED DRUG WITH ANTIVIRAL EFFECT AGAINST NEW SARS-COV-2 CORONAVIRUS | 2021 |
|
RU2746362C1 |
TREATMENT OF INTERFERON-RELATED DEVELOPMENTAL REGULATOR 1 (IFRD1) ASSOCIATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IFRD1 | 2011 |
|
RU2611195C2 |
RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS B VIRUS (HBV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | 2011 |
|
RU2624045C2 |
Authors
Dates
2018-04-19—Published
2014-09-30—Filed